Personalized GLP-1 Injectable (Dual-Action)

Compounded GLP-1 Therapy (Tirzepatide)

Tirzepatide acts on both GLP-1 and GIP receptor pathways. This provider-supervised compounded injectable is part of a personalized weight management program following an online medical evaluation, with dosing adjusted by your provider over time.

Dual-mechanism action (GLP-1 + GIP) for comprehensive support.

Personalized titration and progress monitoring by your provider.

Monthly delivery through a state-licensed compounding pharmacy.

Compounded medications are not FDA-approved. The FDA does not review compounded products for safety, effectiveness, or quality.

Former Customer

“The weight loss has been steady and consistent, and it’s reassuring to have a provider monitoring my progress along the way.”

How It Works

Complete a private online intake, get reviewed by a licensed provider, and receive your personalized tirzepatide plan — shipped monthly from a U.S.-licensed pharmacy.

Frequently Asked Questions

  • No. Compounded tirzepatide is not FDA-approved, and the FDA does not review compounded products for safety, effectiveness, or quality. It’s prepared by a licensed pharmacy and prescribed only after an online medical consultation.

  • After you complete a short online intake, a licensed provider reviews your health history and goals to determine whether tirzepatide is clinically appropriate for you.

  • Yes. Your subscription can be canceled at any time — there’s no long-term commitment required.

  • A licensed provider reviews your intake, typically within 1-2 business days. If appropriate, they’ll prescribe your personalized plan, which ships monthly from a U.S.-licensed pharmacy. If it’s not a fit, you’ll be notified and won’t be charged.

  • Most compounded GLP-1 programs are not billed to insurance. Your intake and provider consultation costs are outlined before you begin, with transparent, all-inclusive pricing.